Literature DB >> 6402815

Stable antibody-producing murine hybridomas.

R T Taggart, I M Samloff.   

Abstract

A method is described for obtaining antibody-producing hybridomas that are preferentially retained in cultures of fused mouse spleen and myeloma cells. Hybridomas are produced by fusing mouse myeloma cells that are deficient in adenosine phosphoribosyltransferase (APRT) with mouse spleen cells containing Robertsonian 8.12 translocation chromosomes. The cell fusion mixtures are exposed to a culture medium that can be utilized only by APRT-positive cells, which results in the elimination of both unfused APRT-deficient myeloma cells and non-antibody-producing APRT-deficient hybridomas that arise by segregation of the 8.12 translocation chromosomes containing the APRT genes and the active heavy chain immunoglobulin gene.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402815     DOI: 10.1126/science.6402815

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  49 in total

1.  Mapping and topographic localization of epitopes of the Yersinia pseudotuberculosis invasin protein.

Authors:  J M Leong; R S Fournier; R R Isberg
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

2.  A monoclonal antibody-linked immunoassay for hemoglobin H disease.

Authors:  M Shyamala; C R Kiefer; H Moscoso; F A Garver
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

3.  Biosynthesis of classical swine fever virus nonstructural proteins.

Authors:  Benjamin Lamp; Christiane Riedel; Gleyder Roman-Sosa; Manuela Heimann; Sylvaine Jacobi; Paul Becher; Heinz-Jürgen Thiel; Tillmann Rümenapf
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 4.  Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors:  B P Ram; P Tyle
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

5.  In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.

Authors:  J J Starling; R S Maciak; N A Hinson; C L Nichols; S L Briggs; B C Laguzza
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.

Authors:  Scott S Graves; Diane M Stone; Carol Loretz; Laura J Peterson; Marina Lesnikova; Billanna Hwang; George E Georges; Richard Nash; Rainer Storb
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

7.  A novel bicomponent hemolysin from Bacillus cereus.

Authors:  D J Beecher; J D MacMillan
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

8.  Platelet receptors for the Streptococcus sanguis adhesin and aggregation-associated antigens are distinguished by anti-idiotypical monoclonal antibodies.

Authors:  K Gong; D Y Wen; T Ouyang; A T Rao; M C Herzberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  An analysis of the expression of cyclophilin C reveals tissue restriction and an intriguing pattern in the mouse kidney.

Authors:  J Friedman; I Weissman; J Friedman; S Alpert
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders.

Authors:  G M Murphy; L S Forno; L Higgins; J M Scardina; L F Eng; B Cordell
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.